Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merdol Ibrahim

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Histopathology|May 20, 2016
PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementationIan A Cree, Richard Booton, Paul Cane, et al.
Journal of Clinical Pathology|June 22, 2011
HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methodsJ M S Bartlett, J Starczynski, Neil Atkey, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2016
ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment RegimenMerdol Ibrahim, Suzanne Parry, Dawn Wilkinson, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 10, 2014
Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panelEmina E Torlakovic, Glenn Francis, John Garratt, et al.
Histopathology|May 13, 2010
A UK NEQAS ICC and ISH multicentre study using the Kreatech Poseidon HER2 FISH probe: intersite variation can be rigorously controlled using FISHJohn M S Bartlett, Fiona M Campbell, Merdol Ibrahim, et al.
Journal of Clinical Pathology|December 10, 2014
Updated UK Recommendations for HER2 assessment in breast cancerEmad A Rakha, Sarah E Pinder, John M S Bartlett, et al.
American Journal of Clinical Pathology|September 19, 2009
Chromogenic in situ hybridization: a multicenter study comparing silver in situ hybridization with FISHJ M S Bartlett, Fiona M Campbell, Merdol Ibrahim, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 5, 2014
Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert CommitteeEmina E Torlakovic, Søren Nielsen, Glenn Francis, et al.
Journal of Cancer Research and Clinical Oncology|July 30, 2013
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinomaEleonora Brunello, Giuseppe Bogina, Emilio Bria, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 10, 2017
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance CharacteristicsEmina E Torlakovic, Carol C Cheung, Corrado D'Arrigo, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Histopathology|May 20, 2016
PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementationIan A Cree, Richard Booton, Paul Cane, et al.
Journal of Clinical Pathology|June 22, 2011
HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methodsJ M S Bartlett, J Starczynski, Neil Atkey, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2016
ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment RegimenMerdol Ibrahim, Suzanne Parry, Dawn Wilkinson, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 10, 2014
Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panelEmina E Torlakovic, Glenn Francis, John Garratt, et al.
Histopathology|May 13, 2010
A UK NEQAS ICC and ISH multicentre study using the Kreatech Poseidon HER2 FISH probe: intersite variation can be rigorously controlled using FISHJohn M S Bartlett, Fiona M Campbell, Merdol Ibrahim, et al.
Journal of Clinical Pathology|December 10, 2014
Updated UK Recommendations for HER2 assessment in breast cancerEmad A Rakha, Sarah E Pinder, John M S Bartlett, et al.
American Journal of Clinical Pathology|September 19, 2009
Chromogenic in situ hybridization: a multicenter study comparing silver in situ hybridization with FISHJ M S Bartlett, Fiona M Campbell, Merdol Ibrahim, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 5, 2014
Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert CommitteeEmina E Torlakovic, Søren Nielsen, Glenn Francis, et al.
Journal of Cancer Research and Clinical Oncology|July 30, 2013
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinomaEleonora Brunello, Giuseppe Bogina, Emilio Bria, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 10, 2017
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance CharacteristicsEmina E Torlakovic, Carol C Cheung, Corrado D'Arrigo, et al.
Pageof 3